Published on in Vol 10 (2024)
This is a member publication of University College London (Jisc)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/56546, first published
.
Journals
- Kohli M, Joshi K, Beck E, Hagiwara Y, Van de Velde N, Igarashi A. Reply to Volkman et al. Comment on “Fust et al. The Potential Economic Impact of the Updated COVID-19 mRNA Fall 2023 Vaccines in Japan. Vaccines 2024, 12, 434”. Vaccines 2024;12(10):1175 View
- Lee A, Davido B, Beck E, Demont C, Joshi K, Kohli M, Maschio M, Uhart M, El Mouaddin N. Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France. Human Vaccines & Immunotherapeutics 2024;20(1) View